Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Food and Drug Administration (U.S. FDA) has approved Jobevnetm (bevacizumab-nwgd), ...

Jabu Mtwa knows first-hand how important sport is for young people in South Africa. As a member of the 2023–2026 cohort of the International Olympic Committee (IOC)’s Young ...